Evidence map›Paper›PMID 12433946›Full record

ArticleThe Journal of physiology2002

Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3.

Sindhu Rajan, Regina Preisig-Müller, Erhard Wischmeyer, Ralf Nehring, Peter J Hanley, Vijay Renigunta, Boris Musset, Günter Schlichthörl, Christian Derst, Andreas Karschin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 151 citations in OpenAlex.

  1. Identification of 14-3-3 Proteins as Binding Partners of TRP Channels.Journal of chemical information and modeling · 2026
    Article
  2. 14-3-3ζ suppresses RANKL signaling by destabilizing TRAF6.The Journal of biological chemistry · 2024
    Article
  3. Compact Programmable Control of Protein Secretion in Mammalian Cells.bioRxiv : the preprint server for biology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. TASK channels: channelopathies, trafficking, and receptor-mediated inhibition.Pflugers Archiv : European journal of physiology · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Two-pore Domain Potassium Channels in Astrocytes.Experimental neurobiology · 2016
    Review
  13. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Review
  14. Article
  15. Article
  16. Phosphoregulatory protein 14-3-3 facilitates SAC1 transport from the endoplasmic reticulum.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Properties, regulation, pharmacology, and functions of the K₂p channel, TRESK.Pflugers Archiv : European journal of physiology · 2015
    Review
  18. Much more than a leak: structure and function of K₂p-channels.Pflugers Archiv : European journal of physiology · 2015
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sindhu RajanInstitute of Physiology, Marburg University, Deutschhausstrasse 2, 35037 Marburg, Germany.
Regina Preisig-Müller
Erhard Wischmeyer
Ralf Nehring
Peter J Hanley
Vijay Renigunta
Boris Musset
Günter Schlichthörl
Christian Derst
Andreas Karschin
Jürgen Daut
Czech Academy of Sciences, Institute of Physiology · CZUniversity of Würzburg · DEPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The two-pore-domain potassium channels TASK-1, TASK-3 and TASK-5 possess a conserved C-terminal motif of five amino acids. Truncation of the C-terminus of TASK-1 strongly reduced the currents measured after heterologous expression in Xenopus oocytes or HEK293 cells and decreased surface membrane expression of GFP-tagged channel proteins. Two-hybrid analysis showed that the C-terminal domain of TASK-1, TASK-3 and TASK-5, but not TASK-4, interacts with isoforms of the adapter protein 14-3-3. A pentapeptide motif at the extreme C-terminus of TASK-1, RRx(S/T)x, was found to be sufficient for weak but significant interaction with 14-3-3, whereas the last 40 amino acids of TASK-1 were required for strong binding. Deletion of a single amino acid at the C-terminal end of TASK-1 or TASK-3 abolished binding of 14-3-3 and strongly reduced the macroscopic currents observed in Xenopus oocytes. TASK-1 mutants that failed to interact with 14-3-3 isoforms (V411*, S410A, S410D) also produced only very weak macroscopic currents. In contrast, the mutant TASK-1 S409A, which interacts with 14-3-3-like wild-type channels, displayed normal macroscopic currents. Co-injection of 14-3-3zeta cRNA increased TASK-1 current in Xenopus oocytes by about 70 %. After co-transfection in HEK293 cells, TASK-1 and 14-3-3zeta (but not TASK-1DeltaC5 and 14-3-3zeta) could be co-immunoprecipitated. Furthermore, TASK-1 and 14-3-3 could be co-immunoprecipitated in synaptic membrane extracts and postsynaptic density membranes. Our findings suggest that interaction of 14-3-3 with TASK-1 or TASK-3 may promote the trafficking of the channels to the surface membrane.

Indexed as

Potassium Channels, Tandem Pore Domain14-3-3 ProteinsAmino Acid MotifsAmino Acid SequenceAnimalsBiological TransportCell LineCell MembraneCOS CellsElectric ConductivityFemaleGene DeletionHumansMolecular Sequence DataMutationNerve Tissue Proteins14-3-3 ProteinsKCNK9 protein, humanKcnk9 protein, ratNerve Tissue ProteinsPeptide FragmentsPotassium ChannelsPotassium Channels, Tandem Pore Domainpotassium channel subfamily K member 3Protein IsoformsTyrosine 3-Monooxygenase

Identifiers

PMID12433946
PMCPMC2290646
OpenAlexW2077822870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.